Holen Sie sich die Stockscreener-App
12.83
11.65%
1.33
Schlusskurs vom Vortag:
$11.50
Offen:
$13.79
24-Stunden-Volumen:
638.88K
Relative Volume:
2.69
Marktkapitalisierung:
$121.25M
Einnahmen:
$7.37M
Nettoeinkommen (Verlust:
$-88.42M
KGV:
-1.362
EPS:
-9.4202
Netto-Cashflow:
$-70.24M
1W Leistung:
+14.85%
1M Leistung:
+14.95%
6M Leistung:
-58.26%
1J Leistung:
-47.93%
1-Tages-Spanne:
$12.68
$14.79
1-Wochen-Bereich:
$11.27
$14.79
52-Wochen-Spanne:
$5.2044
$55.89
Korro Bio Inc Stock (KRRO) Company Profile
Firmenname
Korro Bio Inc
Sektor
Branche
Telefon
617-468-1999
Adresse
60 FIRST STREET, CAMBRIDGE
Compare KRRO vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
12.88 | 108.30M | 7.37M | -88.42M | -70.24M | -9.4202 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.52 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.24 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
705.10 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
312.69 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.42 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-17 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2026-01-29 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2026-01-29 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2026-01-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-01-28 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2026-01-28 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-11-13 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-11-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2025-11-13 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-11-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-11-13 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-13 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2025-11-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-16 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-01-10 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2024-08-14 | Eingeleitet | William Blair | Outperform |
| 2024-03-28 | Bestätigt | H.C. Wainwright | Buy |
| 2024-02-27 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-11-10 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-15 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-09-22 | Herabstufung | Goldman | Buy → Neutral |
| 2021-01-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-22 | Eingeleitet | B. Riley Securities | Buy |
| 2020-07-14 | Eingeleitet | Oppenheimer | Outperform |
| 2020-05-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-10-28 | Eingeleitet | Cowen | Outperform |
| 2019-10-28 | Eingeleitet | Goldman | Buy |
| 2019-10-28 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Korro Bio Inc Aktie (KRRO) Neueste Nachrichten
Cantor Fitzgerald raises Korro Bio stock price target on UCD confidence - Investing.com
Raymond James upgrades Korro Bio stock rating on hyperammonemia pivot - Investing.com
Insider Buying: New Enterprise Associates 17, L.P. Acquires Addi - GuruFocus
Korro Bio, Inc. (KRRO) Reports Q4 Loss, Lags Revenue Estimates - sharewise.com
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - Bitget
Advancing Genetic Medicines with RNA Editing: Inside the OPERA Platform and Therapeutic Strategies - Minichart
Korro Bio, Inc. (KRRO) reports Q4 loss, lags revenue estimates - MSN
Baskett Forest buys Korro Bio (KRRO) shares worth $2.3 million - Investing.com UK
Nea 17 buys Korro Bio (KRRO) shares worth $2.3 million - Investing.com
Korro Bio investor buys $2.3 million in KRRO stock By Investing.com - Investing.com
Korro Bio raises $85 million in private equity financing - Investing.com Nigeria
Korro Bio (NASDAQ: KRRO) expands RNA-editing pipeline as 2025 net loss deepens - Stock Titan
New RNA edit drug, $85M cash boost give Korro Bio runway to 2028 - Stock Titan
Korro Bio, Inc. (KRRO) Announces Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget
Korro Bio (KRRO) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Korro Secures $85M Lifeline After Trial Setback - National Today
Korro Bio Raises $85 Million in Oversubscribed PIPE Financing to Advance RNA Editing Therapies and Extend Cash Runway into 2028 - Minichart
Korro Bio extends cash runway after trial fail, layoffs - The Business Journals
Korro Announces $85 Million Private Placement - citybiz
Korro Bio prices 4.5M shares at $11.11 in private placement - TipRanks
Korro Announces Oversubscribed $85 Million Private Placement - Bitget
Korro Bio raises $85 million in private equity financing By Investing.com - Investing.com Canada
Korro Bio Announces Oversubscribed $85M PIPE Financing - TipRanks
Korro stock surges 17% on $85M private placement financing By Investing.com - Investing.com India
Korro Bio Raises $85 Million in Private Placement, Adds Investor Registration Rights - TradingView
Korro stock surges 17% on $85M private placement financing - Investing.com
Korro Bio, Inc. $KRRO Stock Position Raised by JPMorgan Chase & Co. - MarketBeat
Bond Watch: Does Korro Bio Inc have pricing powerJuly 2025 Reactions & Long-Term Safe Investment Plans - baoquankhu1.vn
Winners Losers: Should you avoid Korro Bio Inc stock right nowWeekly Earnings Recap & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of “Hold” from Analysts - Defense World
KRRO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
KRRO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Bond Watch: What is the next catalyst for Korro Bio IncTrade Volume Report & Precise Swing Trade Alerts - baoquankhu1.vn
Profit Recap: Will Korro Bio Inc benefit from green energy policiesQuarterly Market Summary & Breakout Confirmation Trade Signals - baoquankhu1.vn
Korro Bio, Inc. CEO Ram Aiyar to Present at TD Cowen 46th Annual Health Care Conference - Quiver Quantitative
Korro to Present at the TD Cowen 46th Annual Health Care Conference - Bitget
RNA medicine developer Korro to present at three-day Boston health conference - Stock Titan
Korro Bio (KRRO) Price Target Increased by 12.61% to 19.53 - Nasdaq
Trend Report: What is Origin Agritech Limiteds revenue forecast2025 Market Outlook & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Merger Talk: Is Korro Bio Inc exposed to political riskJuly 2025 Sentiment & Capital Efficient Trading Techniques - baoquankhu1.vn
KRROKorro Bio, Inc. Latest Stock News & Market Updates - Stock Titan
Will Korro Bio Inc stock recover after earningsTrade Risk Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Can Korro Bio Inc. be recession proofQuarterly Trade Report & Long-Term Safe Return Strategies - mfd.ru
Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential - Investing.com South Africa
Korro Bio (NASDAQ:KRRO) Stock Rating Upgraded by Clear Str - MarketBeat
This Chewy Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
KRRO Receives Upgraded Analyst Rating and Price Target Boost fro - GuruFocus
KRRO Receives Upgraded Analyst Rating and Price Target Boost from Clear Street | KRRO Stock News - GuruFocus
Clear Street Upgrades Korro Bio (KRRO) - Nasdaq
William Blair Upgrades Korro Bio (KRRO) - Nasdaq
Korro Bio Shares Rise After William Blair Upgrade - marketscreener.com
Finanzdaten der Korro Bio Inc-Aktie (KRRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Korro Bio Inc-Aktie (KRRO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SANDELL SCOTT D | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
| New Enterprise Associates 17, | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
| Chang Carmen | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
| BASKETT FOREST | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
| Mathers Edward T | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
| Makhzoumi Mohamad | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
| Walker Paul Edward | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
| Florence Anthony A. Jr. | 10% Owner |
Mar 10 '26 |
Buy |
11.11 |
207,100 |
2,300,881 |
1,297,893 |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):